Professor Caso discusses the impact of the current COVID-19 outbreak on the care of stroke patients.
How is the COVID-19 outbreak affecting the care of stroke patients?
Professor Caso has disclosed that she is/was on the speakers bureau for Boehringer Ingelheim, Daicchii Sankyo, BMS Pfizer and Bayer, that she is/was a consultant/advisor for Boehringer Ingelheim, BMS Pfizer, Bayer and that she is/was a grant/research support recipient for Boehringer Ingelheim.